13F HOLDINGS REPORT
Deep Track Capital, LP
Quarter ended Q3 2023 · Filed August 14, 2023 · Accession 0001856083-23-000003
Total Value
$2.43B
Positions
58
Other Managers
0
Confidential Omitted
No
Holdings (55)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | JAZZ PHARMACEUTICALS PLC | JAZZ | 1,250,000 | $155.0M | 7.17% |
| 2 | INSMED INC | INSM | 6,500,000 | $137.2M | 6.35% |
| 3 | IONIS PHARMACEUTICALS INC | IONS | 2,834,069 | $116.3M | 5.38% |
| 4 | TRAVERE THERAPEUTICS INC | TVTX | 7,370,000 | $113.2M | 5.24% |
| 5 | STRUCTURE THERAPEUTICS INC | GPCR | 2,646,782 | $110.0M | 5.09% |
| 6 | IMMUNOVANT INC | IMVT | 5,421,330 | $102.8M | 4.76% |
| 7 | INTRA-CELLULAR THERAPIES INC | 46116X101 | 1,548,252 | $98.0M | 4.54% |
| 8 | ALKERMES PLC | ALKS | 3,000,000 | $93.9M | 4.35% |
| 9 | SPRINGWORKS THERAPEUTICS INC | 85205L107 | 3,546,435 | $93.0M | 4.30% |
| 10 | DYNAVAX TECHNOLOGIES CORP | 268158201 | 6,557,816 | $84.7M | 3.92% |
| 11 | GERON CORP | GERN | 24,170,966 | $77.6M | 3.59% |
| 12 | PLIANT THERAPEUTICS INC | PLRX | 4,050,000 | $73.4M | 3.40% |
| 13 | BICYCLE THERAPEUTICS PLC | BCYC | 2,819,045 | $71.9M | 3.33% |
| 14 | VERONA PHARMA PLC | 925050106 | 3,187,415 | $67.4M | 3.12% |
| 15 | GUARDANT HEALTH INC | GH | 1,500,000 | $53.7M | 2.49% |
| 16 | 4D MOLECULAR THERAPEUTICS IN | FDMT | 2,778,107 | $50.2M | 2.32% |
| 17 | AGENUS INC | AGEN | 30,000,000 | $48.0M | 2.22% |
| 18 | BEAM THERAPEUTICS INC | BEAM | 1,317,316 | $42.1M | 1.95% |
| 19 | AUTOLUS THERAPEUTICS PLC | AUTL | 15,000,000 | $35.7M | 1.65% |
| 20 | INTELLIA THERAPEUTICS INC | NTLA | 835,446 | $34.1M | 1.58% |
| 21 | VIRIDIAN THERAPEUTICS INC | VRDN | 1,279,502 | $30.4M | 1.41% |
| 22 | NURIX THERAPEUTICS INC | NRIX | 2,997,830 | $29.9M | 1.39% |
| 23 | REPARE THERAPEUTICS INC | 760273102 | 2,727,606 | $28.9M | 1.34% |
| 24 | EDITAS MEDICINE INC | EDIT | 3,453,744 | $28.4M | 1.32% |
| 25 | DYNE THERAPEUTICS INC | DYN | 2,499,912 | $28.1M | 1.30% |
| 26 | ANI PHARMACEUTICALS INC | ANIP | 514,021 | $27.7M | 1.28% |
| 27 | AXSOME THERAPEUTICS INC | AXSM | 384,200 | $27.6M | 1.28% |
| 28 | POINT BIOPHARMA GLOBAL INC | 730541109 | 2,781,565 | $25.2M | 1.17% |
| 29 | EDGEWISE THERAPEUTICS INC | EWTX | 2,750,000 | $21.3M | 0.99% |
| 30 | ZURA BIO LTD | ZURA | 2,523,000 | $20.7M | 0.96% |
| 31 | PACIFIC BIOSCIENCES CALIF IN | 69404D108 | 1,451,201 | $19.3M | 0.89% |
| 32 | ACUMEN PHARMACEUTICALS INC | ABOS | 3,916,361 | $18.8M | 0.87% |
| 33 | RAPT THERAPEUTICS INC | 75382E109 | 1,004,561 | $18.8M | 0.87% |
| 34 | PROTHENA CORP PLC | PRTA | 250,000 | $17.1M | 0.79% |
| 35 | VIGIL NEUROSCIENCE INC | 92673K108 | 1,773,409 | $16.7M | 0.77% |
| 36 | ASTRIA THERAPEUTICS INC | 04635X102 | 1,697,415 | $14.1M | 0.65% |
| 37 | NUVATION BIO INC | NUVB | 7,720,688 | $13.9M | 0.64% |
| 38 | MORPHIC HLDG INC | 61775R105 | 216,752 | $12.4M | 0.58% |
| 39 | SILENCE THERAPEUTICS PLC | SLNCF | 1,951,580 | $10.7M | 0.50% |
| 40 | ORCHARD THERAPEUTICS PLC | 68570P101 | 2,041,670 | $10.6M | 0.49% |
| 41 | NEKTAR THERAPEUTICS | NKTR | 17,973,464 | $10.3M | 0.48% |
| 42 | TERNS PHARMACEUTICALS INC | TERN | 1,099,192 | $9.6M | 0.45% |
| 43 | 89BIO INC | 282559103 | 503,100 | $9.5M | 0.44% |
| 44 | INOZYME PHARMA INC | 45790W108 | 1,644,021 | $9.2M | 0.42% |
| 45 | ZENTALIS PHARMACEUTICALS INC | ZNTL | 300,300 | $8.5M | 0.39% |
| 46 | RELMADA THERAPEUTICS INC | RLMD | 2,837,818 | $7.0M | 0.32% |
| 47 | GH RESEARCH PLC | GHRS | 499,400 | $5.9M | 0.27% |
| 48 | COMPASS PATHWAYS PLC | CMPS | 678,360 | $5.6M | 0.26% |
| 49 | MOONLAKE IMMUNOTHERAPEUTICS | MLTX | 108,450 | $5.5M | 0.26% |
| 50 | CENTURY THERAPEUTICS INC | IPSC | 1,022,892 | $3.2M | 0.15% |
| 51 | HERON THERAPEUTICS INC | HRTX | 2,086,704 | $2.4M | 0.11% |
| 52 | FIBROGEN INC | 31572Q808 | 764,700 | $2.1M | 0.10% |
| 53 | ALLAKOS INC | 01671P100 | 228,277 | $995,288 | 0.05% |
| 54 | IMMUNIC INC | IMUX | 308,314 | $773,868 | 0.04% |
| 55 | MINK THERAPEUTICS INC | INKT | 324,867 | $682,221 | 0.03% |